February 22, 2021August 24, 2022
Enhertu Approved in UK for Inoperable, Advanced Breast Cancer
News
Enhertu (trastuzumab deruxtecan) has been granted conditional approval in the U.K. for the treatment of adults with inoperable or metastatic ... Read more
February 18, 2021February 18, 2021
Phase 2 Trial Will Test IRX-2 Combined With Keytruda, Chemotherapy for TNBC
News
An open-label Phase 2 clinical trial will test the safety and efficacy of IRX-2, an experimental immunology-based cancer therapy, in ... Read more
February 15, 2021February 15, 2021
Tukysa Combo Approved in EU for Advanced HER2-Positive Breast Cancer
News
Seagen’s Tukysa (tucatinib) has been approved by the European Commission (EC) as part of a triple-combination therapy for people with previously ... Read more
February 11, 2021February 11, 2021
Trial Testing AL101 in TNBC Doses First Patient
News
The first participant has been dosed in the Phase 2 clinical trial TENACITY, which is evaluating Ayala Pharmaceuticals‘ investigational therapy ... Read more
February 8, 2021February 8, 2021
‘Overwhelmingly Positive’ Data Halts Endoxifen Phase 2 Trial for Invasive Cancer
News
After promising results from patients enrolled to date, Atossa Therapeutics halted an Australian Phase 2 clinical trial evaluating its investigative ... Read more
February 4, 2021February 4, 2021
Theralink Begins Testing New Biomarker Assay for Breast Cancer Tumors
News
Theralink Technologies announced that it has begun testing its new profiling biomarker assay — a test that could potentially provide ... Read more
February 1, 2021February 1, 2021
US Study Enrolling Women to Help Determine Best Screening Practices
News
A national study is seeking women in the U.S. to help determine the safest and best way to screen for ... Read more
January 28, 2021January 28, 2021
Nonprofit Highlights Importance of Global Teamwork for World Cancer Day
News
In honor of World Cancer Day on Feb. 4, the Breast International Group (BIG) emphasized the importance of wide-scale cooperation ... Read more
January 25, 2021January 25, 2021
Enhertu Approved in EU for Inoperable, Advanced Breast Cancer
News
The European Commission has conditionally approved Enhertu (trastuzumab deruxtecan) for adults in the EU with inoperable or metastatic HER2-positive breast cancer ... Read more
January 21, 2021January 21, 2021
Imagio Imaging System for Breast Cancer Diagnosis Approved by FDA
News
Imagio, Seno Medical Instruments’ non-invasive and radiation-free breast imaging technology, has been approved for commercialization by the Center for Devices and ... Read more
January 18, 2021January 18, 2021
Mindfulness Can Alter Brain’s Perception of Pain in Cancer Survivors
News
Mindfulness can significantly improve brain health and pain perception in breast cancer survivors, according to a small Canadian study. The ... Read more
January 14, 2021January 14, 2021
Genetic Test for Advanced Breast Cancer Launched in EU
News
Roche has launched a diagnostic genetic test to detect mutations in the PIK3CA gene in patients with advanced or metastatic ... Read more

October 17, 2018

‘Where’s My Mammogram?’ Campaign Encourages Women to Keep Track of Breast Images

News

Having earlier breast images for comparison greatly improve breast cancer diagnosis and patient outcomes, but many women in the U.S. either don’t know they have a legal right to previous ... Read more

October 16, 2018October 15, 2018

A Half-empty Glass

A Lump in the Road - A Column by Nancy Brier, Columns

I crammed myself into a middle seat, a heavy set lady on one side and a talkative gentleman on the other. It was all too late by the time I ... Read more

October 15, 2018

First Patient Dosed in Phase 1/2 Trial of FLX475 in Breast, Other Advanced Cancers

News

The first patient has been dosed in a Phase 1/2 trial evaluating FLX Bio’s investigational therapy, FLX475, alone and in combination with the PD-1 inhibitor Keytruda (pembrolizumab), as a therapy for triple ... Read more

October 12, 2018

Mammography Screening Does Not Reduce Breast Cancer Mortality, Study Suggests

News

While fewer women die from breast cancer now compared to a decade ago, the decline is no longer associated with mammography screening, but with improved treatment and healthcare, a Norwegian ... Read more

October 10, 2018

Fluorescent Tracer Can Improve Detection of Breast Tumor Margins During Surgery

News

A tumor-specific fluorescent tracer improved the detection of breast tumor margins during surgery and may help surgeons remove cancer cells that would otherwise be missed, according to the first part ... Read more

October 8, 2018

Sales of Limited-edition Crocs to Support Susan G. Komen Breast Cancer Organization

News

In time for National Breast Cancer Awareness Month, Crocs is supporting the efforts of the world’s largest breast cancer organization, Susan G. Komen, through a new limited edition of its footwear. ... Read more

October 3, 2018October 3, 2018

Potential Effects of Thousands of Mutations in BRCA1 Gene Analyzed by Researchers

News

Researchers have analyzed the effects of nearly 4,000 mutations deliberately induced into the BRCA1 gene, one of the genes that increases the likelihood of developing breast cancer and ovarian cancer ... Read more

October 2, 2018October 1, 2018

Don’t Let $5 Stand in the Way of Your Dreams

A Lump in the Road - A Column by Nancy Brier, Columns

“If you don’t have paint, use food coloring,” said my art professor. I’d never heard of that method, but it was a relief. I was 17 years old and taking ... Read more

October 1, 2018

Many Women Being Told of Breast Cancer in Phone Chat with Doctor, Study Finds

News

For more than a decade now, women were more likely to learn they had breast cancer in a telephone conversation with a doctor rather than an office visit, research from the University ... Read more

September 28, 2018

CrownBio Acquires Patient-derived Breast Cancer Mouse Models from University of Utah

News

CrownBio has established an agreement with the University of Utah to acquire and commercialize the university’s unique collection of patient-derived mouse models of breast cancer. The models were developed by ... Read more

September 25, 2018September 24, 2018

Cocktail Hour in the Produce Aisle

A Lump in the Road - A Column by Nancy Brier, Columns

“It’s way too fancy,” I told my husband. “I’d be overdressed.” My new outfit is a beauty — white and lacy, perfect for a summer cocktail party, but too much ... Read more

September 24, 2018

First Patient Dosed in Phase 1b Trial Testing Cirmtuzumab Add-on in HER2-negative Breast Cancer Patients

News

A pilot Phase 1 trial evaluating Oncternal Therapeutic’s investigational therapy cirmtuzumab as an add-on to standard chemotherapy for patients with advanced, HER2-negative breast cancer who cannot receive surgery has started dosing ... Read more

Enhertu Approved in UK for Inoperable, Advanced Breast Cancer

Phase 2 Trial Will Test IRX-2 Combined With Keytruda, Chemotherapy for TNBC

Tukysa Combo Approved in EU for Advanced HER2-Positive Breast Cancer

Trial Testing AL101 in TNBC Doses First Patient

‘Overwhelmingly Positive’ Data Halts Endoxifen Phase 2 Trial for Invasive Cancer

Theralink Begins Testing New Biomarker Assay for Breast Cancer Tumors

US Study Enrolling Women to Help Determine Best Screening Practices

Nonprofit Highlights Importance of Global Teamwork for World Cancer Day

Enhertu Approved in EU for Inoperable, Advanced Breast Cancer

Imagio Imaging System for Breast Cancer Diagnosis Approved by FDA

Mindfulness Can Alter Brain’s Perception of Pain in Cancer Survivors

Genetic Test for Advanced Breast Cancer Launched in EU